Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis

被引：0
|
作者：
T. Korkmaz
S. Seber
U. Kefeli
E. Sari
M. Canhoroz
B. Oven
E. Yildirim
N. Yasar
D. Aydin
O. Balvan
N. Sener
S. Yuksel
A. Mert
O. Polat
F. Yumuk
O. Kanat
M. Gumus
N. S. Turhal
机构：
[1] Dr. Lutfi Kirdar Kartal Education and Research Hospital,Department of Medical Oncology
[2] Marmara University Hospital,Medical Oncology Department
[3] Uludag University Hospital,Medical Oncology Department
[4] Marmara University Hospital,Internal Medicine Department
来源：
Clinical and Translational Oncology | 2013年 / 15卷
关键词：
Platinum sensitive disease; Platinum refracter disease; Second-line chemotherapy; Small cell lung cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：535 / 540
页数：5
相关论文
共 50 条
  • [11] Outcomes of small-cell lung cancer patients treated with second-line chemotherapy: A multi-institutional retrospective analysis
    Garassino, Marina Chiara
    Torri, Valter
    Michetti, Giovanni
    Lo Dico, Monica
    La Verde, Nicla
    Aglione, Stefania
    Mancuso, Andrea
    Gallerani, Elisa
    Galetta, Domenico
    Martelli, Olga
    Collova, Elena
    Fatigoni, Sonia
    Ghidini, Antonio
    Saggia, Chiara
    Bareggi, Claudia
    Rossi, Antonio
    Farina, Gabriella
    Thatcher, Nicholas
    Blackhall, Fiona
    Lorigan, Paul
    Califano, Raffaele
    LUNG CANCER, 2011, 72 (03) : 378 - 383
  • [12] Second-line treatment of small-cell lung cancer
    MacCallum C.
    Gillenwater H.H.
    Current Oncology Reports, 2006, 8 (4) : 258 - 264
  • [13] Outcomes of second-line chemotherapy in patients with relapsed extensive small cell lung cancer
    Froeschl, Sandra
    Nicholas, Garth
    Gallant, Victor
    Laurie, Scott A.
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (02) : 163 - 169
  • [14] Second-line chemotherapy in relapsing or refractory patients with non-small cell lung cancer
    Georgoulias, VA
    LUNG CANCER, 2002, 38 : S61 - S66
  • [15] Second-line treatment with Gemcitabine and Vinorelbine in non-small cell lung cancer (NSCLC): A retrospective analysis of 46 patients
    Czerny, P
    Treutler, D
    Schneider, CP
    Bonnet, R
    8TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2002, : 275 - 278
  • [16] Outcomes of small cell lung cancer (SCLC) patients treated with second-line chemotherapy (SL) with CPT-11: A retrospective analysis
    Lopez Jimenez, A.
    Esquerdo, G.
    Barrajon, E.
    Del Rio Pazos, L.
    Cervera, J.
    Diaz, N.
    Angeles Oyonarte, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [17] Efficacy of Second-line Chemotherapy in Patients With Sensitive Relapsed Small-cell Lung Cancer
    Wakuda, Kazushige
    Miyawaki, Taichi
    Miyawaki, Eriko
    Mamesaya, Nobuaki
    Kawamura, Takahisa
    Kobayashi, Haruki
    Omori, Shota
    Nakashima, Kazuhisa
    Ono, Akira
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Mori, Keita
    Endo, Masahiro
    Takahashi, Toshiaki
    IN VIVO, 2019, 33 (06): : 2229 - 2234
  • [18] Optimal drugs for second-line treatment of patients with small-cell lung cancer
    Rossi, Antonio
    Sacco, Paola Claudia
    Sgambato, Assunta
    Casaluce, Francesca
    Santabarbara, Giuseppe
    Palazzolo, Giovanni
    Maione, Paolo
    Gridelli, Cesare
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (07) : 969 - 976
  • [19] Topotecan effective for second-line treatment of small cell lung cancer
    不详
    IRISH MEDICAL JOURNAL, 1997, 90 (05) : 198 - 198
  • [20] New Advances in the Second-Line Treatment of Small Cell Lung Cancer
    Hurwitz, Jane L.
    McCoy, Francis
    Scullin, Paula
    Fennell, Dean A.
    ONCOLOGIST, 2009, 14 (10): : 986 - 994
12345